About

Held annually in the US and Europe, the Biotech CEO Summits provide high-value, relationship-building opportunities through informal discussions where personal knowledge, insights, and ideas are exchanged with peers. These candid discussions take place in a secure, confidential setting.

Who Participates

Biotech CEO Summits are limited to CEOs focused on leading their organizations through the ever-evolving biotech landscape, transforming individual companies and the industry as a whole.
Non-CEO participants include a select group of industry leaders.

About the Program

The program includes fireside chats, case studies and group discussions that address a range of global issues key to biotech CEOs and their companies. The Summit format facilitates engagement, discussion and interaction with and between all CEOs. The topics are identified in consultation with the advisory board, and include discussions on strategy (asset selection, collaborations, market approach), financing (public and private), communications to all audiences (shareholders, investors, board of directors, patients, regulatory bodies, and team), human resources (board and team development and management), and lessons learned during make or break situations.

Participant Benefits

An important benefit of participating in the Summit is the development of trusted relationships between CEOs and the select group of other industry thought leaders. The program is designed to ensure all CEOs spend quality time together. Everyone is encouraged to participate in the candid discussions, to share their experiences and to ask questions. All CEOs are invited to suggest topics
for discussion. Throughout the Summit, networking sessions, dinners and activities provide opportunities for CEOs to meet one-on-one and build relationships.

Companies Represented By Their CEOs at Past EU and US Summits

4SC AG
ABIVAX
Ablynx
Abzena PLC
Achilles Therapeutics
Acucela
Adjuvance Technologies
Aelin Therapeutics
Aimmune Therapeutics
Akari Therapeutics
Albireo Pharma
Amplyx Pharmaceuticals
Anake Therapeutics
Anocca
Apexigen
Apogenix AG
Arcturus Therapeutics
Arecor
Aristea Therapeutics
ARMO Biosciences Inc
Artelo Biosciences, Inc.
Artidis
Asher Biotherapeutics
Ashvattha Therapeutics
Aspen Biosciences, Inc.
Assembly Biosciences
AtG Therapeutics
Atomwise, Inc.
Aura Biosciences
Autifony Therapeutics
AVEO Oncology
AzurRx
binxhealth
BioPharma
BC Platforms
Bioasis Technologies Inc.
BioAtla
BioInvent International
bioLytical Laboratories
Biophytis
Blade Therapeutics
BliNK Biomedical SAS
BRAINCURES
Brinter
Cadrenal Therapeutics
Caliber BioSciences
Calithera Biosciences
Calliditas Therapeutics
Cancer Prevention Pharmaceuticals, Inc.
Cantargia
Cardior Pharmaceuticals
Carmell Therapeutics
CatalYm GmbH
CellFE
Celltheon
ChemoCentryx
Cold Genesys, Inc.
Conatus Pharmaceuticals
Concert Pharmaceuticals, Inc.
Context Therapeutics
Crescendo Biologics
Curve Therapeutics
CXL Ophthalmics
Cytovia Therapeutics
DelMar Pharmaceuticals
Dicerna Pharmaceuticals
Drawbridge Health
Earli
Eden BioPharma
Elex Biotech, Inc.
Eloxx Pharmaceuticals
EOLO USA INC
Epics Therapeutics
Epilepsygtx Limited
e-Therapeutics
Ethicann Pharmaceuticals Inc.
Ethris GmbH

Evotec AG
Evox Therapeutics
Exicure
Function Oncology
G1 Therapeutics B.V.
Gate Neurosciences Inc
GeNeuro
Genome Medical, Inc.
Glycostem Therapeutics BV
Graybug Vision
Harpoon Therapeutics
hC Bioscience
Heptares Therapeutics Ltd
Heyman Biotech
Histogenics
Iconic Therapeutics Inc.
IGEM Therapeutics
Ileo Science
Immunicum
ImmusanT, Inc.
IMV Inc.
Incysus Therapeutics, Inc.
Indaptus
Indi Molecular
InProTher
InteRNA Technologies B.V
Intravacc
Intus Bio
Iolyx Therapeutics
Jounce Therapeutics
Jubilant Therapeutics
Kezar Life Sciences
Kojin Therapeutics
Kubota Pharmaceutical
Kymab Ltd
Labcyte Inc.
LabGenius
Lantern Pharma
Leading Biosciences
Lucy Therapeutics
Lyric Pharmaceuticals Inc
Lysogene
Mateon Therapeutics
Matinas Biopharma Holdings
MatriSys Bioscience, Inc.
Maverick Therapeutics
MDXHealth
Meditope Biosciences, Inc.
Menlo Therapeutics Inc
Mereo BioPharma Group plc
metaLinear Ltd
Microbion
Milestone Pharmaceuticals
MiNA Therapeutics Limited
Minoryx Therapeutics
MiroBio
Mithra
Mnemo Therapeutics
MorphoSys AG
Navigen, Inc.
NeRRe Therapeutics
Neuron23
Nexstim Plc
Nkarta Therapeutics
NKILT Therapeutics
Nucleai
Nuclideum
Nurix
NuVox Pharma
Oak Hill Bio
Ocera
Ochre Bio
OcuTerra Therapeutics
OncoOne
OncoSpherix
Oppilotech Ltd
Ordaōs Bio
Orpheris, Inc.

Orum Therapeutics
Oxford BioMedica Ltd
Oxford BioTherapeutics Ltd
PACT Pharma
PalisadeBIO
Peptomyc S.L.
Personalized Medicine Partners
Perspective Therapeutics
Petra Pharma
PharmAkea
Phoenix Molecular Designs
Precirix
PredxBio
Principia Biopharma Inc.
PRISM BioLab Co
Probiodrug AG
Protagonist Therapeutics, Inc.
PTM Therapeutics, Inc.
Quell Therapeutics
Qureator
Recursion Pharmaceuticals
Refuge Biotechnologies
Reneo Pharmaceuticals
ReNeuron
Retrophin
Ribbon Biolabs
Ritter Pharmaceuticals
Roswell Biotechnologies, Inc.
Sangamo Therapeutics
Saphetor
Satellos Bioscience
Scenic Biotech
Second Genome, Inc.
Selvita SA
Sensorion
Shield Therapeutics
Sigmoid Pharma
SiSaf
Sorriso Pharmaceuticals
Sosei Heptares
Spectral Medical Inc.
Spirovant
Spruce Biosciences
Star Therapeutics
STC Biologics
Strand Therapeutics
Sutro Biopharma
SutroVax
Switch Therapeutics
Symic Bio
Synthetic Genomics, Inc.
TCR² Therapeutics
Tenpoint Therapeutics
TenSixteen Bio
Terray Therapeutics
TesoRx Pharma, LLC
TiGenix NV
Tillotts Pharma AG
Toivoa Therapeutics
Tolero Pharmaceuticals, Inc.
Travere Therapeutics
Tubulis
Turning Point
TxCell SA
Unicycive Therapeutics
Vaccitech
Valley Fever Solutions
Valo Therapeutics
Veracyte, Inc.
ViaCyte
Viewpoint Molecular Targeting
Vivace Therapeutics
Wave Life Sciences
WinSanTor
Xencor, Inc.
XOMA

Organizers

Demy-Colton produces highly specialized targeted investor and business development conferences exclusively for the biopharmaceutical and life sciences industry. With a proven track record and deep domain knowledge, we develop programs that add value and routinely exceed the expectations of our participants.